Lexin Medical: Announcement on the progress of using idle raised funds for cash management
Lexin Medical 2026 Announcement Securities Code: 300562 Securities Abbreviation: Lexin Medical Announcement Number: 2026-066 Guangdong Lexin Medical Electronics Co., Ltd.
Announcement on the progress of using idle raised funds for cash management
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
The ninth meeting of the fifth board of directors of Guangdong Lexin Medical Electronics Co., Ltd. (hereinafter referred to as the "Company") held on April 8, 2026 and the 2025 Annual Shareholders' Meeting held on April 30, 2026 reviewed and approved the "Proposal on the Use of Idle Raised Funds for Cash Management" and agreed that the company's usage limit shall not exceed RMB 17,000. The idle raised funds of RMB 10,000 can be used to purchase cash management products such as structured deposits and certificates of deposit from commercial banks with high security, good liquidity and capital guarantee agreement. The term is valid for 12 months from the date of review and approval by the company’s shareholders’ meeting. Within this limit, the funds can be used on a rolling basis. For details, please refer to the company’s relevant announcements disclosed on the cninfo.com (www.cninfo.com.cn) on April 10, 2026 and April 30, 2026.
According to the above resolution, the company has recently handled the related business of using part of the idle raised funds for cash management at China Guangfa Bank Co., Ltd. (hereinafter referred to as "Guangfa Bank"). The specific situation is hereby announced as follows:
1. Basic situation of the company’s purchase of bank financial products this time
Amount Revenue Product Product Estimation Is it related to the entrusting party? Entrusted party Product name
(10,000 yuan) Starting date Maturity date Type Annual rate of return Contact China Guangfa Bank “Salary increase 16
No. 233, 2026 1,300.00
0.50%
Customized version of RMB structural capital guaranteed floating
Our company China Guangfa Bank 2026/7/3 2026/10/12 to No deposit (linked to AUD/USD income type
1.75% yuan interval cumulative structure) (medium
11,879.00
Shan Branch)
2. Approval Procedure
The "Proposal on the Use of Idle Raised Funds for Cash Management" has been reviewed and approved at the ninth meeting of the company's fifth board of directors and the 2025 annual shareholders' meeting, and the sponsor issued a clear agreement. company
The amount and period of cash management announced by Lexin Medical in 2026 are within the scope of approval and do not need to be submitted to the board of directors and shareholders' meeting for review.
3. Investment risks and risk control measures
- Investment risks
(1) Although cash management products have undergone strict evaluation and can guarantee the safety of principal and are low-risk investments, the financial market is greatly affected by the macroeconomy, and it cannot be ruled out that this investment will be affected by market fluctuations;
(2) The company will intervene in a timely and appropriate manner based on changes in the economic situation and financial markets, so the actual returns from short-term investments are unpredictable;
(3) Operational risks of relevant staff.
- In response to investment risks, the following measures are planned:
(1) After deliberation and approval by the company's board of directors and shareholders' meeting, the company's board of directors authorizes the company's chairman or his authorized person to sign relevant contract documents within the above-mentioned investment quota. Relevant personnel of the company's financial center will promptly analyze and track cash management product investment directions and project progress. If the assessment finds that there are risk factors that may affect the company's capital security, corresponding measures will be taken in a timely manner to control investment risks;
(2) The company’s internal audit department is responsible for auditing and supervising the use and custody of cash management products, conducting comprehensive inspections of all cash management product projects on a regular basis, and reasonably predicting the possible gains and losses of each investment based on the principle of prudence;
(3) The independent directors and the audit committee have the right to supervise and inspect the use of funds, and can hire professional institutions to conduct audits when necessary;
(4) The company will do a good job in relevant information disclosure in accordance with the relevant regulations of the Shenzhen Stock Exchange.
4. Impact on the company
Based on the principles of standardized operations, risk prevention, prudent investment, and value preservation and appreciation, the company used idle raised funds to purchase cash management products from commercial banks with high security, good liquidity, and capital guarantee agreements. This was implemented on the premise of ensuring that the liquidity required for the company's investment projects will not be affected and the safety of funds will not be affected.
Lexin Medical 2026 Announcement
Affect the normal development of the company's investment projects. By making modest investments in cash management products, companies can improve
Fund utilization efficiency, increase investment efficiency, further enhance the company's overall performance level, and provide benefits to the company and all shareholders
To seek more returns, there is no disguised change in the use of raised funds, and there is no harm to the company and the entire
interests of individual shareholders, especially small and medium shareholders.
- As of the date of this announcement, the company has used idle raised funds for cash management in the past twelve months.
situation
Amount Income Product Product Entrusting party to obtain income Entrusted party Product name Remarks (10,000 yuan) Starting date Maturity date Type (10,000 yuan)
China Guangfa Bank “salary increase of 16%”
No. 164, 2026
2026 May 2026 June Capital guaranteed and floating Redeemed company China Guangfa Bank RMB structured deposit 11,879.00 16.642 March 29 March 30 Income-type return (linked to the euro-dollar range
Cumulative structure) (Zhongshan Branch)
China Guangfa Bank “salary increase of 16%”
No. 126, 2026
2026 May 2026 June Capital guaranteed and floating Redeemed company China Guangfa Bank RMB structured deposit 1,500.00 3.723 May 8 May 29 Income-type return (linked to the range of the euro against the U.S. dollar
Cumulative structure) (Zhongshan Branch)
China Guangfa Bank “salary increase of 16%”
No. W, No. 7, 2026
2026 1 2026 4 Capital guaranteed and floating Redeemed company China Guangfa Bank Customized version of RMB structural deposit 11,300.00 50.482 May 6 May 15 Income type Repayment (linked to the Australian dollar against the US dollar zone
cumulative period) (Zhongshan Branch)
China Guangfa Bank “salary increase of 16%”
No. W, No. 7, 2026
2026 1 2026 4 Capital guaranteed and floating Redempted company China Guangfa Bank Customized version of RMB structural deposit 1,600.00 7.148 October 6th October 15th Income type Repayment (linked to the Australian dollar against the US dollar zone
cumulative period) (Zhongshan Branch)
China Guangfa Bank “salary increase of 16%”
No. "W" No. 430 of 2025
October 2025 December 2025 Capital guaranteed and floating Redempted company Guangfa Bank Futures customized version of RMB structural 14,500.00 50.054 August 21 August 30 Income type Return deposit (linked to AUD/USD
Interval accumulation) (Zhongshan Branch)
China Guangfa Bank “salary increase of 16%”
No. "W" No. 430 of 2025
October 2025 December 2025 Capital guaranteed and floating Redeemed company Guangfa Bank Futures customized version of RMB structural 1,700.00 5.868 May 21 May 30 Income type Return deposit (linked to Australian dollar against US dollar)
Interval accumulation) (Zhongshan Branch)
Lexin Medical 2026 Announcement
China Guangfa Bank “salary increase of 16%”
No. "W" No. 339 of 2025
2025 7 2025 10 Capital guaranteed floating Redempted company Guangfa Bank Futures customized version of RMB structural 2,400.00 12.618 January 10 January 13 Income type return deposit (linked to AUD/USD
Interval accumulation) (Zhongshan Branch)
China Guangfa Bank “Wuhua Tianbao” W
2025 Issue 701 Customized
2025 July 2025 October 2025 Capital guaranteed floating Redempted company China Guangfa Bank version of RMB structured deposit 8,900.00 47.777 February 8 December 13 Income type return (linked to gold spot bullish stage
Ladder type) (Zhongshan Branch)
China Guangfa Bank “salary increase of 16%”
No. "W" No. 336 of 2025
July 2025 October 2025 Capital guaranteed and floating Redeemed company Guangfa Bank Futures customized version of RMB structural 5,600.00 30.06 October 8 October 13 Income type Return deposit (linked to Australian dollar against US dollar)
Interval accumulation) (Zhongshan Branch)
6. Documents for reference
The bank’s product instructions and electronic receipts.
Announcement is hereby made.
Guangdong Lexin Medical Electronics Co., Ltd.
board of directors
July 6, 2026